$XLRN ACCELERON PHARMA INC Insider Trading Week 41/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC in week 41/2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | M | 27.97 | 4,550 | 127,264 | 31,850 | |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | M | 24.11 | 8,101 | 195,315 | 16,689 | |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | M | 7.12 | 4,182 | 29,776 | 937 | |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | M | 24.11 | 4,210 | 101,503 | 24,790 | |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | M | 7.12 | 2,381 | 16,953 | 5,119 | |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | M | 5.28 | 1,115 | 5,887 | 16,761 | |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | M | 5.28 | 10,984 | 57,996 | 0 | |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | M | 3.88 | 954 | 3,702 | 4,561 | |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Option Exercise | M | 5.28 | 7,124 | 37,615 | 17,876 | |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Sell | S | 34.14 | 16,833 | 574,679 | 75,866 | 92.7 K to 75.9 K (-18.16 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Buy | M | 27.97 | 4,550 | 127,264 | 92,699 | 88.1 K to 92.7 K (+5.16 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Buy | M | 24.11 | 8,101 | 195,315 | 88,149 | 80 K to 88.1 K (+10.12 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Buy | M | 7.12 | 4,182 | 29,776 | 80,048 | 75.9 K to 80 K (+5.51 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Sell | S | 34.00 | 28 | 952 | 75,866 | 75.9 K to 75.9 K (-0.04 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Sell | S | 33.37 | 19,616 | 654,586 | 75,894 | 95.5 K to 75.9 K (-20.54 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Buy | M | 24.11 | 4,210 | 101,503 | 95,510 | 91.3 K to 95.5 K (+4.61 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Buy | M | 7.12 | 2,381 | 16,953 | 91,300 | 88.9 K to 91.3 K (+2.68 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Buy | M | 5.28 | 1,115 | 5,887 | 88,919 | 87.8 K to 88.9 K (+1.27 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Buy | M | 5.28 | 10,984 | 57,996 | 87,804 | 76.8 K to 87.8 K (+14.30 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Buy | M | 3.88 | 954 | 3,702 | 76,820 | 75.9 K to 76.8 K (+1.26 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Sell | S | 34.98 | 1,561 | 54,604 | 75,866 | 77.4 K to 75.9 K (-2.02 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Sell | S | 34.31 | 14,448 | 495,711 | 77,427 | 91.9 K to 77.4 K (-15.73 %) |
Oct 11 2016 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | SVP & Chief Scienti ... | Buy | M | 5.28 | 7,124 | 37,615 | 91,875 | 84.8 K to 91.9 K (+8.41 %) |